We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

55 hedge funds and large institutions have $9.9M invested in PDS Biotechnology in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

15% more funds holding

Funds holding: 48 → 55 (+7)

1% more capital invested

Capital invested by funds: $9.81M → $9.9M (+$96K)

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

1.85% less ownership

Funds ownership: 18.15% → 16.3% (-1.8%)

Holders
55
Holders Change
+7
Holders Change %
+14.58%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
12
Reduced
13
Closed
6
Calls
$234K
Puts
–
Net Calls
+$234K
Net Calls Change
-$79K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$599K
2
UBS Group
UBS Group
Switzerland
+$396K
3
Citadel Advisors
Citadel Advisors
Florida
+$338K
4
Renaissance Technologies
Renaissance Technologies
New York
+$144K
5
Squarepoint
Squarepoint
New York
+$133K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.96M
2
IGGA
Iron Gate Global Advisors
Utah
-$89.3K
3
Bank of America
Bank of America
North Carolina
-$35.7K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$27.1K
5
RWM
Ritholtz Wealth Management
New York
-$23.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
MG
26
Marex Group
$18.6K – – –
VPIM
27
Vanguard Personalized Indexing Management
California
$18.6K -$19.7K -14,544 -51%
Raymond James Financial
28
Raymond James Financial
Florida
$18.4K -$136 -100 -0.7%
WG
29
Wealth Group
North Carolina
$18K -$2.72K -2,000 -13%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$17.8K -$16.8K -12,346 -48%
SFP
31
Sandbox Financial Partners
Maryland
$16.8K – – –
Mercer Global Advisors
32
Mercer Global Advisors
Colorado
$16.6K +$14 +10 +0.1%
SWP
33
Stratos Wealth Partners
Ohio
$15K +$15.3K +11,303 New
CSS
34
Cubist Systematic Strategies
Connecticut
$14.4K +$14.7K +10,861 New
JWBC
35
J.W. Burns & Co
New York
$13.7K – – –
GD
36
Grandfield & Dodd
New York
$13.3K +$13.6K +10,000 New
Morgan Stanley
37
Morgan Stanley
New York
$9.89K -$13.4K -9,881 -57%
KSWA
38
Kathleen S. Wright Associates
Pennsylvania
$9.31K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$9K +$9.31K +6,856 +2,381%
Wells Fargo
40
Wells Fargo
California
$7.09K – – –
BTI
41
Blue Trust Inc
Georgia
$5.99K – – –
CFD
42
Creative Financial Designs
Indiana
$3.99K – – –
TRCT
43
Tower Research Capital (TRC)
New York
$2.66K -$9.99K -7,359 -79%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$1.51K – – –
TC
45
Truvestments Capital
Florida
$1.48K – – –
Fidelity Investments
46
Fidelity Investments
Massachusetts
$1.36K -$2.38K -1,753 -63%
RA
47
Rise Advisors
New York
$1.12K +$699 +515 +158%
Bank of America
48
Bank of America
North Carolina
$861 -$35.7K -26,306 -98%
JP Morgan Chase
49
JP Morgan Chase
New York
$823 – – –
Osaic Holdings
50
Osaic Holdings
Arizona
$688 +$23 +17 +3%
1
2
3

PDSB Hedge Fund Activity: Q2 2025 in Review

55 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q2 2025, worth a combined $9.9M — up 0.98% from $9.81M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new PDSB positions and 6 closed out — a net gain of 7 holders — while 12 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, adding an estimated $599K. The largest seller was Armistice Capital, cutting an estimated $2.96M.

  • 55 institutional investors held PDS Biotechnology (PDSB) as of Q2 2025, up from 48 in Q1 2025.
  • Funds reported $9.9M of PDS Biotechnology stock for Q2 2025, up 0.98% quarter-over-quarter.
  • 13 funds opened new PDS Biotechnology positions in Q2 2025 and 6 closed out, a net change of +7 holders.
  • The largest PDS Biotechnology buyer in Q2 2025 was Vanguard Group, an estimated $599K added.
  • The largest PDS Biotechnology seller in Q2 2025 was Armistice Capital, an estimated $2.96M sold.

Based on aggregated 13F filings for Q2 2025.